U.K. Pharmaceuticals & Biotech Most Popular Stocks

AstraZeneca

Market Cap: UK£181.6b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

GSK

Market Cap: UK£70.9b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Haleon

Market Cap: UK£29.4b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Hikma Pharmaceuticals

Market Cap: UK£3.2b

Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.

HUTCHMED (China)

Market Cap: UK£1.7b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Oxford Nanopore Technologies

Market Cap: UK£1.5b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.

Genus

Market Cap: UK£1.4b

Produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.

Oxford Biomedica

Market Cap: UK£536.8m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Avacta Group

Market Cap: UK£341.9m

Engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally.

Allergy Therapeutics

Market Cap: UK£300.8m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally.

PureTech Health

Market Cap: UK£292.7m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Diaceutics

Market Cap: UK£134.1m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

Scancell Holdings

Market Cap: UK£123.0m

A clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom.

Bioventix

Market Cap: UK£83.6m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

4basebio

Market Cap: UK£74.6m

Engages in the research, development, manufacturing, and sale of synthetic DNA and RNA products in Europe, the United States, and internationally.

Faron Pharmaceuticals Oy

Market Cap: UK£72.3m

Operates as a clinical stage drug discovery and development company.

ECO Animal Health Group

Market Cap: UK£65.0m

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally.

Poolbeg Pharma

Market Cap: UK£63.4m

A clinical-stage biopharmaceutical company, engages in developing immunotherapy for cancer in the United Kingdom.

Shield Therapeutics

Market Cap: UK£49.9m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

hVIVO

Market Cap: UK£45.0m

Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.

Sareum Holdings

Market Cap: UK£44.3m

A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.

Coiled Therapeutics

Market Cap: UK£36.2m

A clinical-stage oncology company, develops and commercialises clinical-stage oncology therapeutics in the United Kingdom and internationally.

Arecor Therapeutics

Market Cap: UK£30.6m

A clinical stage biotechnology company, develops therapeutics that address diabetes, obesity and other cardiometabolic diseases in the United Kingdom.

Hemogenyx Pharmaceuticals

Market Cap: UK£29.7m

A clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer in the United Kingdom and the United States.

SkinBioTherapeutics

Market Cap: UK£24.0m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

ImmuPharma

Market Cap: UK£22.5m

Engages in the research, development, and commercialization of peptide-based therapeutics for autoimmune diseases, infectious diseases, and metabolic disorders in the United Kingdom and internationally.

genedrive

Market Cap: UK£20.9m

Engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.

ProBiotix Health

Market Cap: UK£16.6m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

IXICO

Market Cap: UK£16.4m

Provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally.

Palatin Technologies

Market Cap: US$21.1m

A biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States.

Oxford BioDynamics

Market Cap: UK£15.5m

Operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom.

Fusion Antibodies

Market Cap: UK£14.7m

A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.

Aptamer Group

Market Cap: UK£13.0m

Provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.

Genflow Biosciences

Market Cap: UK£12.3m

Engages in the research and development of gene therapies in the United Kingdom, Belgium, and the United States.

Solvonis Therapeutics

Market Cap: UK£7.8m

A clinical-stage biopharmaceutical company, develops medicines for addiction, psychiatry, and neurology disorders.

Cardiogeni

Market Cap: UK£6.7m

A clinical stage biotechnology company, develops heart failure medicines.